Bavarian Nordic’s Chikungunya vaccine trial hits primary endpoint, posing competition to Valneva’s near-approved candidate by Editor | Jun 21, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0 DENMARK — Bavarian Nordic has achieved a significant milestone in its phase 3 clinical trial for a... Read More
IVI,Bharat Biotech start global Phase II/III clinical trial of Chikungunya vaccine by Editor | Aug 25, 2021 | Diseases News, LATEST NEWS, WORLD NEWS | 0 INDIA – The International Vaccine Institute (IVI) and Bharat Biotech has announced the... Read More